Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Stupp, Roger, Mason, Warren P., van den Bent, Martin J., Weller, Michael, Fisher, Barbara, Taphoorn, Martin J.B., Belanger, Karl, Brandes, Alba A., Marosi, Christine, Bogdahn, Ulrich, Curschmann, Jürgen, Janzer, Robert C., Ludwin, Samuel K., Gorlia, Thierry, Allgeier, Anouk, Lacombe, Denis, Cairncross, J. Gregory, Eisenhauer, Elizabeth, Mirimanoff, René O.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa043330

Cited by (1,070)

Items 501–600 of 1,070

A comprehensive profile of recurrent glioblastoma
Benito Campos, Lars Rønn Olsen, Thomas Haargaard Urup, Hans Skovgaard Poulsen · 2016 · Oncogene
Novel anti-angiogenic therapies for malignant gliomas
Norden, Andrew D, Drappatz, Jan, Wen, Patrick Y · 2008 · The Lancet Neurology
Intravenous magnetic nanoparticle cancer hyperthermia
James F. Hainfeld, Huang · 2013 · International Journal of Nanomedicine
Antiangiogenic therapies for high-grade glioma
Andrew David Norden, Jan Drappatz, Patrick Yung Wen · 2009 · Nature Reviews Neurology
Seizure characteristics and prognostic factors of gliomas
Melissa Kerkhof, Charles J. Vecht · 2013 · Epilepsia
Immunocompetent murine models for the study of glioblastoma immunotherapy
Taemin Oh, Shayan Fakurnejad, Eli T. Sayegh, Allan Clark, Michael E. Ivan, Matthew Z. Sun, Michael Safaee, Orin G. Bloch, Charles David James, Andrew T. Parsa · 2014 · Journal of Translational Medicine
Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition
Anna Segerman, Mia Niklasson, Caroline Haglund, Tobias Bergström, Malin Jarvius, Yuan Xie, Ann Westermark, Demet Sönmez, Annika Hermansson, Marianne Kastemar et al. · 2016 · Cell Reports
Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience
Frank Joseph Attenello, Debraj Raj Mukherjee, Ghazala Datoo, Matthew J. McGirt, Eileen M. Bohan, JON D. WEINGART, Alessandro Olivi, Alfredo Quiñones‐Hinojosa, Henry Brem · 2008 · Annals of Surgical Oncology
Radiation-induced cognitive impairment-from bench to bedside
Dana M. Greene-Schloesser, Mike E. C. Robbins · 2012 · Neuro-Oncology
Targeted Modulation of MGMT: Clinical Implications
Lili Liu, Stanton L. Gerson · 2006 · Clinical Cancer Research
MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma
Meiying Wu, Haixian Zhang, Changjun Tie, Chunhong Yan, Zhiting Deng, Qian Wan, Xin Liu, Fei Yan, Hairong Zheng · 2018 · Nature Communications
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Christina A. Von Roemeling, Yifan Wang, Yaqing Qie, Hengfeng Yuan, Zhao Hai, Xiujie Liu, Zhaogang Yang, Mingming Yang, Weiye Deng, Katelyn A. Bruno et al. · 2020 · Nature Communications
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
Emily Padfield, Hayley Patricia Ellis, Kathreena Mary Kurian · 2015 · Frontiers in Oncology
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Weihua Zhou, Yangyang Yao, Andrew J. Scott, Kari Wilder-Romans, Joseph Dresser, Christian K. Werner, Hanshi Sun, Drew W. Pratt, Peter Sajjakulnukit, Shuang George Zhao et al. · 2020 · Nature Communications
Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors
Yoshihiro Muragaki, Jiro Akimoto, Takashi Maruyama, Hiroshi Iseki, Soko Ikuta, Masayuki Nitta, Katsuya Maebayashi, Taiichi Saito, Yoshikazu Okada, Sadao Kaneko et al. · 2013 · Journal of neurosurgery
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid, Jillian A. Phallen, Jing Zeng, Alfred Pokmeng See, Dimitrios Mathios, Chelsea Gottschalk, Sarah E. Nicholas, Meghan D. Kellett, Jacob Ruzevick, Christopher Mitchell Jackson et al. · 2014 · PLoS ONE
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
Mathias Kunz, Niklas Thon, Sabina Eigenbrod, Christian Johannes Hartmann, Rupert Egensperger, Jochen Wolfgang Herms, Julia Geisler, Christian Jean la Fougère, Juergen Lutz, Jennifer Linn et al. · 2011 · Neuro-Oncology
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
Burt Nabors, Karen Fink, Tom Mikkelsen, Danica Grujičić, Rafal Tarnawski, Do Hyun Nam, Maria Mazurkiewicz, Michael E. Salacz, Lynn Stuart Ashby, Vittorina Zagonel et al. · 2015 · Neuro-Oncology
Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
Ashwatha Narayana, Patrick Kelly, John G. Golfinos, Erik C. Parker, Glyn Johnson, Edmond A. Knopp, David Zagzag, Ingeborg Fischer, Shahzad Raza, Praveen Medabalmi et al. · 2008 · Journal of neurosurgery
Emerging Applications of Artificial Intelligence in Neuro-Oncology
Jeffrey D. Rudie, Andreas M. Rauschecker, Robert Nick Bryan, Christos A. Davatzikos, Suyash Mohan · 2019 · Radiology
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., Stacpoole, P. W. · 2014 · Investigational New Drugs
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow, Swati Naik, Sunitha Kakarla, Vita S. Brawley, Donald R. Shaffer, Zhongzhen Yi, Nino Carlo Rainusso, Meng-Fen Wu, Hao Liu, Yvonne Kew et al. · 2012 · Molecular Therapy
Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin G. Bloch, Courtney A. Crane, Yelena S. Fuks, Rajwant Kaur, Manish Kumar Aghi, Mitchel Stuart Berger, Nicholas Arthur Butowski, Susan Marina Chang, Jennifer Leigh Clarke, Michael W. McDermott et al. · 2013 · Neuro-Oncology
NFKBIA Deletion in Glioblastomas
Markus Bredel, Denise M. Scholtens, Ajay K. Yadav, Angel A. Alvarez, Jaclyn J. Renfrow, James P. Chandler, Irene L.Y. Yu, Maria Stella Carro, Fangping Dai, Michael J. Tagge et al. · 2010 · New England Journal of Medicine
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang, Aida Rashidi, Junfei Zhao, Caylee Silvers, Hanxiang Wang, Brandyn A. Castro, Abby Ellingwood, Yu Han, Aurora Lopez‐Rosas, Μαρκέλλα Ζαννίκου et al. · 2023 · Nature Communications
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma
Hoogstrate, Youri, Draaisma, Kaspar, Ghisai, Santoesha A., van Hijfte, Levi, Barin, Nastaran, de Heer, Iris, Coppieters, Wouter, van den Bosch, Thierry P.P., Bolleboom, Anne, Gao, Zhenyu et al. · 2023 · Cancer Cell
Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
Yunhong Tian, Qiang Xie, Jie He, Xiaojun Luo, Tao Zhou, Ying Liu, 黄作平, Yunming Tian, Dan Sun, Kaitai Yao · 2015 · BMC Cancer
Paediatric and adult malignant glioma: close relatives or distant cousins?
Chris Jones, Lara Perryman, Darren R. Hargrave · 2012 · Nature Reviews Clinical Oncology
Modern Brain Tumor Imaging
Marc C. Mabray, Ramon Barajas, Soonmee Cha · 2015 · Brain Tumor Research and Treatment
Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker*
Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, Guido Reifenberger, Marie‐France Hamou, Annie‐Claire Diserens, Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl et al. · 2008 · Brain Pathology
Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
Terrie Ellen Taylor, Frank B. Furnari, Webster K. Cavenee · 2012 · Current Cancer Drug Targets
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos, Daniel J. Silver, Erin E. Mulkearns-Hubert, Alvaro G. Alvarado, Soumya M. Turaga, Mia Dahl Sørensen, Patricia A. Rayman, William A. Flavahan, James S. Hale, Kevin Stoltz et al. · 2016 · Stem Cells
Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study
Kuo‐Chen Wei, Po‐Chun Chu, Hay-Yan Jack Wang, Chiung-Yin Huang, Pin‐Yuan Chen, Hong‐Chieh Tsai, Ya-Jui Lin, Pei-Yun Lee, I-Chou Tseng, Li-Ying Feng et al. · 2013 · PLoS ONE
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
Peter Vajkoczy, Pjotr G. Knyazev, Andrea Kunkel, Hans‐Holger Capelle, Sandra Behrndt, Hendrik von Tengg‐Kobligk, Fabian M. Kiessling, Uta Eichelsbacher, Marco Essig, Tracy‐Ann Read et al. · 2006 · Proceedings of the National Academy of Sciences
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal, Seppo Ylä‐Herttuala, John F. Martin, Peter C. Warnke, Philippe Meneï, D.J.A. Eckland, Judith Kinley, Richard Kay, Zvi Ram · 2013 · The Lancet Oncology
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Hiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, William T. Curry, Stephen S. F. Yip, Masae Nitta, Anoop P. Patel, Zachary R. Barnard, Anat O Stemmer-Rachamimov, David N. Louis et al. · 2011 · Neuro-Oncology
Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro
Amy M. McCord, Muhammad Jamal, Uma T. Shankavarum, Frederick F. Lang, Kevin A. Camphausen, Philip J. Tofilon · 2009 · Molecular Cancer Research
Developmental origins and emerging therapeutic opportunities for childhood cancer
Mariella G. Filbin, Michelle Monje · 2019 · Nature Medicine
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
Messaoudi, Khaled, Clavreul, Anne, Lagarce, Frédéric · 2015 · Drug Discovery Today
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
Yi-Ping Yang, Yueh Chien, Guang‐Yuh Chiou, Jong‐Yuh Cherng, Mong‐Lien Wang, Wen‐Liang Lo, Yuh-Lih Chang, Pin‐I Huang, Yi‐Wei Chen, Yang‐Hsin Shih et al. · 2011 · Biomaterials
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
Michael P. Gustafson, Yi Lin, Kent C. New, Peggy A. Bulur, Brian Patrick O’Neill, Dennis A. Gastineau, Allan B. Dietz · 2010 · Neuro-Oncology
Serum GFAP is a diagnostic marker for glioblastoma multiforme
Carla S. Jung, Christian Foerch, Anne Schänzer, A. Heck, Karl Heinz Plate, Volker Seifert, Helmuth Steinmetz, Andreas Raabe, Matthias Sitzer · 2007 · Brain
Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
Graham Dickson and Hugh MacLeod, Danielle Bozek, Nishani Rajakulendran, Vernon Monteiro, Moloud Ahmadi, Zachary Steinhart, Michelle M. Kushida, Helen Yu, Fiona J. Coutinho, Florence M.G. Cavalli et al. · 2018 · Cell Reports
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Yang Xing, Huayue Geng, Rui Guo, Lei Yang, Ziling Liu, Hong Wang · 2023 · Frontiers in Immunology
Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas
Lefranc, Florence, Facchini, Vincenzo, Kiss, Robert · 2007 · The Oncologist
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
Melanie Jackson, Foteini Hassiotou, Anna K. Nowak · 2014 · Carcinogenesis
Leptomeningeal disease: current diagnostic and therapeutic strategies
Gautam Nayar, Tiffany Ejikeme, Pakawat Chongsathidkiet, Aladine A. Elsamadicy, Kimberly Blackwell, Jeffrey Melson Clarke, Shivanand Pramod Lad, Peter Edward Fecci · 2017 · Oncotarget
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
Michiel Smits, Jonas A. Nilsson, Shahryar E. Mir, Petra M. van der Stoop, Esther Hulleman, Johanna M. Niers, Philip C. De Witt Hamer, Víctor E. Márquez, Jacqueline J Cloos, Anna M. Krichevsky et al. · 2010 · Oncotarget
Glioblastoma Multiforme Therapy and Mechanisms of Resistance
Yulian P. Ramirez, Jessica L. Weatherbee, Richard T. Wheelhouse, Alonzo H. Ross · 2013 · Pharmaceuticals
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
Gabriele D. Maurer, Daniel P. Brucker, Oliver Bähr, Patrick N. Harter, Elke Hattingen, Stefan Walenta, Wolfgang Mueller‐Klieser, Joachim Peter Steinbach, Johannes Rieger · 2011 · BMC Cancer
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Huang, Zhi, Cheng, Lin, Guryanova, Olga A., Wu, Qiulian, Bao, Shideng · 2010 · Protein & Cell
Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas
Emily C. Brantley, Etty N. Benveniste · 2008 · Molecular Cancer Research
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan Dz-Wei Chow, Christopher D. Guzman, Guangchuan Wang, Florian Schmidt, Mark W. Youngblood, Lupeng Ye, Youssef Errami, Matthew B. Dong, Michael A. Q. Martinez, Sensen Zhang et al. · 2017 · Nature Neuroscience
Macrophages and microglia: the cerberus of glioblastoma
Alice Buonfiglioli, Dolores Hambardzumyan · 2021 · Acta Neuropathologica Communications
Advances Toward an Understanding of Brainstem Gliomas
Sarah S. Donaldson, Fred H. Laningham, Paul Graham Fisher · 2006 · Journal of Clinical Oncology
Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma
Dan R. Laks, Michael D. Masterman-Smith, Koppany Visnyei, Brigitte Angénieux, Nicholas M. Orozco, Ian M. Foran, William H. Yong, Harry V. Vinters, Linda M. Liau, Jorge A. Lazareff et al. · 2009 · Stem Cells
Advances in Glioblastoma Therapy: An Update on Current Approaches
Ramcharan Singh Angom, Naga Malleswara Rao Nakka, Santanu Bhattacharya · 2023 · Brain Sciences
Extracellular Vesicles Modulate the Glioblastoma Microenvironment via a Tumor Suppression Signaling Network Directed by miR-1
Bronisz, Agnieszka, Wang, Yan, Nowicki, Michal O., Peruzzi, Pierpaolo, Ansari, Khairul I., Ogawa, Daisuke, Balaj, Leonora, De Rienzo, Gianluca, Mineo, Marco, Nakano, Ichiro et al. · 2014 · Cancer Research
Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
Karen Saida Aboody, Joseph Najbauer, Marianne Z. Metz, Massimo D’Apuzzo, Margarita Gutova, Alexander J. Annala, Timothy Walter Synold, Larry A. Couture, Suzette Blanchard, Rex A. Moats et al. · 2013 · Science Translational Medicine
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
Matthias Simon, Md. Ismail Hosen, Konstantinos Gousias, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, Marco Gessi, Johannes Schramm, Kari Hemminki, Andreas Waha, Rajiv Kumar · 2014 · Neuro-Oncology
Human Bone Marrow–Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Δ24-RGD to Human Gliomas
Raymund L.M. Yong, Naoki Shinojima, Juan Fueyo-Margareto, Joy Gumin, Giacomo G. Vecil, Frank C. Marini, Oliver Bögler, Michael Andreeff, Frederick F. Lang · 2009 · Cancer Research
Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma
Jing Li, Meihua Wang, Minhee Won, Edward G. Shaw, Christopher T. Coughlin, Walter John Curran, Minesh P. Mehta · 2010 · International Journal of Radiation Oncology*Biology*Physics
Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
Marc H.A. Jansen, Dannis Gilbert van Vuurden, William Peter Vandertop, Gertjan J.L. Kaspers · 2011 · Cancer Treatment Reviews
Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents
David A. Reardon, Patrick Yung Wen · 2006 · The Oncologist
Bevacizumab and chemotherapy for recurrent glioblastoma
Phioanh Leia Nghiemphu, W. Liu, Yurim Lee, T. Than, Colin Alexander Graham, Albert Lai, R. M. Green, Whitney B. Pope, Linda M. Liau, Paul S. Mischel et al. · 2009 · Neurology
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
Dongyao Yan, Joanna Kowal, Leila Akkari, Alberto J. Schuhmacher, Jason T. Huse, Brian L. West, Johanna A. Joyce · 2017 · Oncogene
EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling
Yutian Wei, Chenfei Lu, Peng Zhou, Lin Zhao, Xiao Lyu, Jianxing Yin, Zhumei Shi, Yongping You · 2020 · Neuro-Oncology
Boron Neutron Capture Therapy: A Review of Clinical Applications
Timothy Dean Malouff, Danushka S. Seneviratne, Daniel K. Ebner, William C. Stross, Mark Raymond Waddle, Daniel Michael Trifiletti, Sunil Krishnan · 2021 · Frontiers in Oncology
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Amir Abdollahi, Judah Folkman · 2010 · Drug Resistance Updates
Health-related quality of life and cancer clinical trials
David Osoba · 2011 · Therapeutic Advances in Medical Oncology
Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner
Kailiang Zhang, Xiaotian Sun, Xuan Zhou, Lei Han, Luyue Chen, Zhendong Shi, Anling Zhang, Minhua Ye, Qixue Wang, Chaoyong Liu et al. · 2014 · Oncotarget
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
Jason T. Huse, HEIDI S. PHILLIPS, Cameron Brennan · 2011 · Glia
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
David A. Reardon, Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, James E. Herndon, Jennifer E. Marcello, Julie A. Norfleet, Roger E. McLendon, John Howard Sampson et al. · 2009 · Journal of Neuro-Oncology
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
Kyeung Min Joo, Jinkuk Kim, Juyoun Jin, Misuk Kim, Ho Jun Seol, Johongir M. Muradov, Heekyoung Yang, Yoon‐La Choi, Woong‐Yang Park, Doo‐Sik Kong et al. · 2013 · Cell Reports
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs
Ahmad R. Safa, Mohammad Reza Saadatzadeh, Aaron Cohen‐Gadol, Karen E. Pollok, Khadijeh Bijangi‐Vishehsaraei · 2015 · Genes & Diseases
PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors
Brian M. Mcellin, Cristel V. Camacho, Bipasha Mukherjee, Brandon Hahm, Nozomi Tomimatsu, Robert M. Bachoo, Sandeep Burma · 2010 · Cancer Research
Gold nanoparticles in combinatorial cancer therapy strategies
Jaber Beik, Maziar Khateri, Zohreh Khosravi, Seyed Kamran Kamrava, Siavash Kooranifar, Habib Ghaznavi, Ali Shakeri‐Zadeh · 2019 · Coordination Chemistry Reviews
AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
Tzu-Chi Chen, Jian‐Ying Chuang, Chiung‐Yuan Ko, Tzu‐Jen Kao, Pei-Yu Yang, Chun-Hui Yu, Ming-Sheng Liu, Siou-Lian Hu, Yu-Ting Tsai, Hardy Chan et al. · 2019 · Redox Biology
The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
Kashif Parvez, Aatif Parvez, Gelareh Mohammed Zadeh · 2014 · International Journal of Molecular Sciences
The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma
Lee Cooper, David A. Gutman, Candace Chisolm, Christina Appin, Jun Kong, Yuan Rong, Tahsin Kurç, Erwin G. Van Meir, Joel Haskin Saltz, Carlos S. Moreno et al. · 2012 · American Journal Of Pathology
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen, Mats Holmberg, Morten Mau‐Sørensen, Michael Kosteljanetz, Helle Broholm, Marie‐Thérése Stockhausen, Hans Skovgaard Poulsen · 2010 · Neuro-Oncology
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost
Soleakhena Ken, L. Vieillevigne, X. Franceries, L. Simon, C. Supper, Jean-Albert Lotterie, Thomas Filleron, V. Lubrano, I. Berry, Emmanuelle Cassol et al. · 2013 · Radiation Oncology
Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma
Monica Fedele, Laura Cerchia, Silvia Pegoraro, Riccardo Sgarra, Guidalberto Manfioletti · 2019 · International Journal of Molecular Sciences
Glioblastoma in England: 2007–2011
Andrew R. Brodbelt, David C. Greenberg, Tim Winters, Matthew Williams, Sally Vernon, Vincent Peter Collins · 2015 · European Journal of Cancer
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D. Prados, Sara Ann Byron, Nhan L. Tran, Joanna J. Phillips, Annette M. Molinaro, Keith Lloyd Ligon, Patrick Yung Wen, John G. Kuhn, Ingo K. Mellinghoff, John de Groot et al. · 2015 · Neuro-Oncology
The Central Nervous System
Matthew P. Frosch, Douglas C. Anthony, Umberto De Girolami · 2010 · Elsevier eBooks
Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma
Vaubel, Rachael A., Tian, Shulan, Remonde, Dioval, Schroeder, Mark A., Mladek, Ann C., Kitange, Gaspar J., Caron, Alissa, Kollmeyer, Thomas M., Grove, Rebecca, Peng, Sen et al. · 2020 · Clinical Cancer Research
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
Giuseppe Caracciolo Minniti, Vitaliana De Sanctis, Roberta Muni, F. Filippone, Alessandro Bozzao, Maurizio Valeriani, Mattia Falchetto Osti, Ugo De Paula, Gaetano Lanzetta, Vincenzo Tombolini et al. · 2008 · Journal of Neuro-Oncology
Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
John de Groot, Kathleen R. Lamborn, Susan Marina Chang, Mark R. Gilbert, Timothy Francis Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank Scott Lieberman, H. Ian Robins et al. · 2011 · Journal of Clinical Oncology
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma
Alba Ariela Brandes, Enrico Franceschi, Alicia Tosoni, Francesca Benevento, Luciano Scopece, Valeria Mazzocchi, A. Bacci, Raffaele Agati, Fabio Calbucci, Mario Ermani · 2009 · Cancer
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu‐Emerson, Matija Snuderl, Nathaniel D. Kirkpatrick, Jermaine Goveia, Christian J. Davidson, Yuhui Huang, Lars Riedemann, Justin M. Taylor, Percy S. Ivy, Dan Gabriel Duda et al. · 2013 · Neuro-Oncology
miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
Kenta Ujifuku, Norisato Mitsutake, Shu Takakura, Michiko Matsuse, Vladimir Saenko, Keiji Suzuki, Kentaro Hayashi, Takayuki Matsuo, Kensaku Kamada, Izumi Nagata et al. · 2010 · Cancer Letters
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
Alba Ariela Brandes, A. Tosoni, G Cavallo, Roberta Bertorelle, V. Gioia, Enrico Franceschi, M. Biscuola, Valeria Blatt, Lucio Crinò, Mario Ermani · 2006 · British Journal of Cancer
Current data and strategy in glioblastoma multiforme.
Gabriel Iacob, Eduard B. Dinca · 2009 · PubMed Central
Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation
Gary D. Kao, Zibin Jiang, Anne Marie Fernandes, Anjali Gupta, Amit M. Maity · 2007 · Journal of Biological Chemistry
Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to Glioma
Forrest M. Kievit, Omid Veiseh A, Chen Fang, Narayan Bhattarai, Donghoon Lee, Richard G. Ellenbogen, Miqin Zhang · 2010 · ACS Nano
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587
Javier M. Figueroa, Lynette M. Phillips, Tal Shahar, Anwar Hossain, Joy Gumin, Hoon Kim, Andrew J. Bean, George A. Călin, Juan Fueyo-Margareto, Edgar T. Walters et al. · 2017 · Cancer Research
Glioblastoma: Microenvironment and Niche Concept
Davide Schiffer, Laura Annovazzi, Cristina Casalone, Cristiano Corona, Marta Mellai · 2018 · Cancers
CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
Guoqing Wang, Zongliang Zhang, Kunhong Zhong, Zeng Wang, Yang Nian, Xin Tang, Hexian Li, Qizhong Lu, Zhiguo Wu, Boyang Yuan et al. · 2022 · Molecular Therapy
Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
Kirson, Eilon D, Schneiderman, Rosa S, Dbalý, Vladimír, Tovaryš, František, Vymazal, Josef, Itzhaki, Aviran, Mordechovich, Daniel, Gurvich, Zoya, Shmueli, Esther, Goldsher, Dorit et al. · 2009 · BMC Medical Physics